Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-26 @ 2:42 AM
Study NCT ID:
NCT03401502
Status:
COMPLETED
Last Update Posted:
2019-04-10
First Post:
2018-01-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency
Sponsor:
TSH Biopharm Corporation Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-07
First Submit QC Date:
None
Study First Post Date:
2018-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-08
Last Update Post Date:
2019-04-10
Last Update Post Date Type:
ACTUAL